Kit/Flt3 kinase inhibitors (Universite de Strasbourg)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKit/Flt3 kinase inhibitors (Universite de Strasbourg)
Drug Alias Nameresorcylic acid lactone analogs (Universite de Strasbourg)NW-499NW-466
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsStem cell growth factor receptor inhibitorsAngiogenesis inhibitors +[5] 
TargetsStem cell growth factor receptorTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversité de Strasbourg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSATT ConectusUniversité de Strasbourg
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A